Skip to main content

S. 2952

Referred to Committee

FDA Modernization Act of 2021

Introduced 10/7/2021•117th Congress•Senate

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

10/7/2021 • Senate

Summary

FDA Modernization Act of 2021

This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, computer modeling, and other human biology-based test methods.

Introduced in Senate • 10/7/2021

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (16)

Party Breakdown

5
Democrats
9
Republicans
2
Independents

Sponsor

S[
Sen. Paul, Rand [R-KY]

Republican • KY

Sponsored 10/7/2021

Cosponsors (15)

S[
Sen. Booker, Cory A. [D-NJ]

D-NJ

Joined 10/7/2021

S[
Sen. Braun, Mike [R-IN]

R-IN

Joined 10/7/2021

S[
Sen. Kennedy, John [R-LA]

R-LA

Joined 10/7/2021

S[
Sen. Luján, Ben Ray [D-NM]

D-NM

Joined 10/7/2021

S[
Sen. Collins, Susan M. [R-ME]

R-ME

Joined 10/18/2021

S[
Sen. Rubio, Marco [R-FL]

R-FL

Joined 1/18/2022

Bill Journey

Originated in the Senate

Introduced

October 7, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate10/7/2021

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors15